4572.T

Carna Biosciences, Inc. [4572.T] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

4572.T Stock Summary

Top 10 Correlated ETFs

4572.T


Top 10 Correlated Stocks

4572.T


In the News

4572.T Financial details

Company Rating
Buy
Market Cap
12.63B
Income
-1.85B
Revenue
1.06B
Book val./share
277.65
Cash/share
257.72
Dividend
-
Dividend %
-
Employees
65
Optionable
No
Shortable
Yes
Earnings
03 Aug 2023
P/E
-6.33
Forward P/E
-
PEG
13.95
P/S
11.93
P/B
2.67
P/C
2.88
P/FCF
-
Quick Ratio
10.48
Current Ratio
12.31
Debt / Equity
0.12
LT Debt / Equity
0.03
-
-
EPS (TTM)
-40.19
EPS next Y
-
EPS next Q
-
EPS this Y
135.39%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-4.54%
Revenue last 5Y
12.94%
Revenue Q/Q
-22.04%
EPS Q/Q
-
-
-
-
-
SMA20
17.74%
SMA50
58.38%
SMA100
40.39%
Inst Own
-
Inst Trans
-
ROA
-37%
ROE
-45%
ROC
-0.39%
Gross Margin
83%
Oper. Margin
-168%
Profit Margin
-175%
Payout
-
Shs Outstand
17.05M
Shs Float
13.85M
-
-
-
-
Target Price
-
52W Range
447.0-984.0
52W High
-24.7%
52W Low
+65.77%
RSI
54.17
Rel Volume
1.06
Avg Volume
832.47K
Volume
882.1K
Perf Week
-3.14%
Perf Month
47.9%
Perf Quarter
-1.07%
Perf Half Y
-5.24%
-
-
-
-
Beta
1.54584
-
-
Volatility
20.2%, 78.72%
Prev Close
-0.94%
Price
741
Change
-8.86%

4572.T Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
Revenue per share
77.94294.5192.15158.92101.84
Net income per share
-125.0276.05-90.33-42.1-99.1
Operating cash flow per share
-116.49135.69-102.53-121.04-52.02
Free cash flow per share
-122.52131.83-108.12-124.32-61.27
Cash per share
139.96451.31349.55300.72248.14
Book value per share
91.65353.84310.92339.93267.44
Tangible book value per share
91.65353.84310.92339.93267.44
Share holders equity per share
91.65353.84310.92339.93267.44
Interest debt per share
7267.6735.5442.8322.45
Market cap
8.71B23.12B14.91B13.99B7.08B
Enterprise value
8.05B18.93B11.04B10.71B4B
P/E ratio
-7.227.91-13.42-26.18-5.25
Price to sales ratio
11.557.2113.156.935.11
POCF ratio
-7.7315.65-11.82-9.1-10
PFCF ratio
-7.3516.1-11.21-8.86-8.49
P/B Ratio
9.8263.93.241.94
PTB ratio
9.8263.93.241.94
EV to sales
10.665.99.745.312.89
Enterprise value over EBITDA
-6.819.43-10.44-21.43-3.22
EV to operating cash flow
-7.1312.81-8.75-6.97-5.65
EV to free cash flow
-6.7813.19-8.3-6.79-4.8
Earnings yield
-0.140.04-0.07-0.04-0.19
Free cash flow yield
-0.140.06-0.09-0.11-0.12
Debt to equity
0.990.40.260.260.17
Debt to assets
0.50.280.210.210.15
Net debt to EBITDA
0.57-4.293.666.562.48
Current ratio
4.1856.476.879.4
Interest coverage
-107.69119.77-143.37-135.32-239.15
Income quality
0.931.621.142.890.54
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
0.05-0.030.050.030.18
Capex to revenue
-0.08-0.01-0.06-0.02-0.09
Capex to depreciation
-4.59-4.47-5.55-2.17-3.73
Stock based compensation to revenue
00.010.050.030.04
Graham number
507.74778.14794.95567.44772.24
ROIC
1.22-0.20.280.240.52
Return on tangible assets
-0.680.15-0.23-0.1-0.32
Graham Net
54.53316.02271.57217.09206.63
Working capital
1.27B4.22B3.98B4.54B3.67B
Tangible asset value
887.45M3.85B3.82B4.31B3.64B
Net current asset value
788.95M3.75B3.7B4.2B3.48B
Invested capital
0.770.190.110.130.08
Average receivables
00000
Average payables
1.75M1.83M2.35M1.91M2.13M
Average inventory
114.37M105.1M101.97M107.51M114.51M
Days sales outstanding
00000
Days payables outstanding
0.75.582.886.184.17
Days of inventory on hand
161.29174.8198.55297.87252.19
Receivables turnover
00000
Payables turnover
524.4765.42126.6659.0287.44
Inventory turnover
2.262.091.841.231.45
ROE
-1.360.21-0.29-0.12-0.37
Capex per share
-6.02-3.86-5.6-3.28-9.25

Quarterly Fundamentals Overview

Last date of statement is 2023-03-31 for Q1

Metric History 2022-03-312022-06-302022-09-302022-12-31 2023-03-31
Revenue per share
41.232.712.43014.33
Net income per share
-1.12-3.27-4.140-32.78
Operating cash flow per share
00000
Free cash flow per share
00000
Cash per share
362.6344.5235.430257.72
Book value per share
337.5742.0737.480277.65
Tangible book value per share
337.5742.0737.480277.65
Share holders equity per share
337.5742.0737.480277.65
Interest debt per share
34.763.873.17016.24
Market cap
14.1B94.69B89.96B07.52B
Enterprise value
9.68B90.42B86.56B-3.08B3.7B
P/E ratio
-233.33-68.82-51.570-3.62
Price to sales ratio
25.42332.39351.32033.15
POCF ratio
00000
PFCF ratio
00000
P/B Ratio
3.121.422.8101.71
PTB ratio
3.121.422.8101.71
EV to sales
17.46317.37338.06-10.5716.29
Enterprise value over EBITDA
2.25K-293.87-202.35.66-7.22
EV to operating cash flow
00000
EV to free cash flow
00000
Earnings yield
0000-0.07
Free cash flow yield
00000
Debt to equity
0.180.180.150.170.12
Debt to assets
0.150.150.130.150.11
Net debt to EBITDA
-1.02K13.917.945.667.47
Current ratio
10.4910.4311.89.412.31
Interest coverage
8.94-219.14-363.53-500.18-564.5
Income quality
00000
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
92.3555.6359.120452.53
ROIC
00.080.150.210.16
Return on tangible assets
0-0.07-0.1-0.13-0.11
Graham Net
306.2637.5330.240227.47
Working capital
4.75B4.57B4B3.67B4.41B
Tangible asset value
4.54B4.42B3.94B3.64B4.4B
Net current asset value
4.44B4.27B3.76B3.48B4.25B
Invested capital
0.10.090.080.080.06
Average receivables
00000
Average payables
1.57M665K1.86M2.6M2M
Average inventory
111.47M112.82M114.93M117.6M127.69M
Days sales outstanding
00000
Days payables outstanding
1.81.067.193.693.76
Days of inventory on hand
238.23250.92258.65222.82253.22
Receivables turnover
00000
Payables turnover
49.9884.5712.5324.423.96
Inventory turnover
0.380.360.350.40.36
ROE
0-0.08-0.11-0.15-0.12
Capex per share
00000

4572.T Frequently Asked Questions

What is Carna Biosciences, Inc. stock symbol ?

Carna Biosciences, Inc. is a JP stock and trading under the symbol 4572.T

What is Carna Biosciences, Inc. stock quote today ?

Carna Biosciences, Inc. stock price is $741 today.

Is Carna Biosciences, Inc. stock public?

Yes, Carna Biosciences, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap